DE3889536D1 - Behandlung von krebs mit somatostatin und mit analogen davon. - Google Patents

Behandlung von krebs mit somatostatin und mit analogen davon.

Info

Publication number
DE3889536D1
DE3889536D1 DE3889536T DE3889536T DE3889536D1 DE 3889536 D1 DE3889536 D1 DE 3889536D1 DE 3889536 T DE3889536 T DE 3889536T DE 3889536 T DE3889536 T DE 3889536T DE 3889536 D1 DE3889536 D1 DE 3889536D1
Authority
DE
Germany
Prior art keywords
somatostatin
analogs
treating cancer
analog
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3889536T
Other languages
English (en)
Other versions
DE3889536T2 (de
Inventor
John Taylor
Arthur Bogden
Jacques-Pierre Moreau
David Coy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tulane University
Original Assignee
Tulane University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tulane University filed Critical Tulane University
Publication of DE3889536D1 publication Critical patent/DE3889536D1/de
Application granted granted Critical
Publication of DE3889536T2 publication Critical patent/DE3889536T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE3889536T 1987-11-18 1988-11-18 Behandlung von krebs mit somatostatin und mit analogen davon. Expired - Lifetime DE3889536T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12193787A 1987-11-18 1987-11-18
US07/231,136 US5073541A (en) 1987-11-18 1988-08-11 Treatment of small cell lung cancer with somatostatin analogs
PCT/US1988/004126 WO1989004666A1 (en) 1987-11-18 1988-11-18 Treatment of cancer with somatostatin and analogs thereof

Publications (2)

Publication Number Publication Date
DE3889536D1 true DE3889536D1 (de) 1994-06-16
DE3889536T2 DE3889536T2 (de) 1994-11-24

Family

ID=26819987

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3889536T Expired - Lifetime DE3889536T2 (de) 1987-11-18 1988-11-18 Behandlung von krebs mit somatostatin und mit analogen davon.

Country Status (8)

Country Link
US (1) US5073541A (de)
EP (1) EP0344297B1 (de)
JP (1) JPH02502022A (de)
AT (1) ATE105482T1 (de)
CA (1) CA1330037C (de)
DE (1) DE3889536T2 (de)
IE (1) IE65809B1 (de)
WO (1) WO1989004666A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441935A (en) * 1987-03-31 1995-08-15 Imperial Cancer Research Technology Ltd. Growth factor receptors
GR1002475B (el) * 1988-12-05 1996-11-26 Novartis Ag (Novartis Sa) (Novartis Inc.) Μεθοδος παρασκευης πεπτιδικων παραγωγων.
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5460785A (en) * 1989-08-09 1995-10-24 Rhomed Incorporated Direct labeling of antibodies and other protein with metal ions
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
US5411943A (en) * 1992-02-25 1995-05-02 Biomeasure, Inc. Hepatoma treatment with somatostatin analogs
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US5871711A (en) * 1992-06-23 1999-02-16 Diatide, Inc. Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
DE69330868T2 (de) * 1992-07-27 2002-04-25 Biomeasure Inc Antagonisten des neuromedin b rezeptors
US5569741A (en) * 1992-07-27 1996-10-29 Biomeasure, Inc. Cyclic octapeptide neuromedin B receptor antagonists
US5462926A (en) * 1992-07-27 1995-10-31 Biomeasure, Inc. Neuromedin B receptor antagonists which demonstrate selectivity
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US6355613B1 (en) * 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
US6262229B1 (en) 1996-12-04 2001-07-17 Biomeasure Incorporated Somatostatin antagonists
KR100479149B1 (ko) * 1996-12-04 2005-03-25 더 어드미니스트레이터즈 오브 더 튜래인 어듀케이셔널 훤드 소마토스타틴 길항제
US6150333A (en) * 1998-07-30 2000-11-21 Biomeasure, Inc. Methods of using a somatostatin analogue
US6465613B1 (en) 1998-11-19 2002-10-15 Tulane University Hydrophilic somatostatin analogs
US6316414B1 (en) 2000-07-31 2001-11-13 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
WO2003028527A2 (en) * 2001-09-21 2003-04-10 The Administrators Of The Tulane Educational Fund Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
US7771727B2 (en) * 2002-03-01 2010-08-10 The Administrators Of The Tulane Educational Fund Conjugates of therapeutic or cytotoxic agents and biologically active peptides
AU2003259172A1 (en) * 2002-07-24 2004-02-09 The Salk Institute For Biological Studies Receptor (sstr4)- selective somatostatin analogs
EP1610805A2 (de) * 2003-03-10 2006-01-04 Biogen Idec Inc. Thiol-vermittelte wirkstoffanbindung an targeting-peptide
US20130183263A1 (en) 2012-01-17 2013-07-18 Steven Hoffman Pharmaceutical compositions and methods
US8481498B1 (en) 2012-01-17 2013-07-09 Steven Hoffman Pharmaceutical compositions and methods
CN104220057B (zh) * 2012-01-17 2017-11-03 迪美公司 药物组合物和方法
US10646552B2 (en) 2012-01-17 2020-05-12 Tyme, Inc. Pharmaceutical compositions and methods
US10272068B2 (en) 2012-01-17 2019-04-30 Tyme, Inc. Pharmaceutical compositions and methods
US9326962B2 (en) 2013-10-22 2016-05-03 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US10813901B2 (en) 2013-10-22 2020-10-27 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
US10751313B2 (en) 2013-10-22 2020-08-25 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
US9585841B2 (en) 2013-10-22 2017-03-07 Tyme, Inc. Tyrosine derivatives and compositions comprising them
US9763903B2 (en) 2013-10-22 2017-09-19 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291022A (en) * 1975-03-11 1981-09-22 Sandoz Ltd. Organic compounds
US4133782A (en) * 1976-06-07 1979-01-09 The Salk Institute For Biological Studies Somatostatin analogs with dissociated biological activities
US4211693A (en) * 1977-09-20 1980-07-08 The Salk Institute For Biological Studies Peptides with para-substituted phenylalanine
DE19375086I2 (de) * 1979-11-27 2003-01-09 Novartis Ag Polypeptide Verfahren zu ihrer Herstellung pharmazeutische Zusammensetzungen die diese Polypeptide enthalten und ihre Verwendung
US4282143A (en) * 1980-06-13 1981-08-04 American Home Products Corporation Octapeptides lowering growth hormone
US4328135A (en) * 1980-06-13 1982-05-04 American Home Products Corporation Octapeptides lowering growth hormone
DK81082A (da) * 1981-03-06 1982-09-07 Sandoz Ag Fremgangsmaade til fremstilling af polypeptider
US4820811A (en) * 1982-04-21 1989-04-11 Research Corporation Amine reacted therapeutic agents
DE3303345A1 (de) * 1983-02-02 1984-08-02 Hoechst Ag, 6230 Frankfurt Cyclische peptide mit somatostatin-wirkung
US4485101A (en) * 1983-10-11 1984-11-27 Administrators Of The Tulane Educational Fund Peptides
US4816438A (en) * 1984-08-31 1989-03-28 The Salk Institute For Biological Studies Insulin-selective somatostatin analogs
US4684620A (en) * 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
GR862206B (en) * 1985-09-12 1986-12-31 Univ Tulane Therapeutic somatostatin analogs
US4703034A (en) * 1986-04-28 1987-10-27 Merck & Co., Inc. Novel cyclic tetrapeptide

Also Published As

Publication number Publication date
CA1330037C (en) 1994-06-07
US5073541A (en) 1991-12-17
IE65809B1 (en) 1995-11-15
JPH02502022A (ja) 1990-07-05
ATE105482T1 (de) 1994-05-15
IE883450L (en) 1989-05-18
EP0344297B1 (de) 1994-05-11
EP0344297A1 (de) 1989-12-06
EP0344297A4 (en) 1990-10-03
DE3889536T2 (de) 1994-11-24
WO1989004666A1 (en) 1989-06-01

Similar Documents

Publication Publication Date Title
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DE3779149D1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
DE3789320D1 (de) Verabreichungsinstrument zum Einführen von festen Medikamenten.
DE68907909D1 (de) Praeparat zur behandlung von erektionsstoerungen.
DK162965C (da) Anvendelse af et difluornucleosid eller et farmaceutisk acceptabelt salt deraf til fremstilling af et laegemiddel til behandling af neoplasma
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DE69027865D1 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
DE3878905T2 (de) Vorrichtung zum heilen oder lindern von krankheiten der mundhoehle.
DE68921273D1 (de) System zum kontinuierlichen Behandeln von Halbleitersubstraten.
DE3882775T2 (de) Zusammensetzung zur Behandlung von parodontaler Krankheit.
DK0502925T3 (da) præparat til behandling af inflammatoriske tarmlidelser
ATE81004T1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
DE58906239D1 (de) Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn.
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
ATE181240T1 (de) Verwendung von somatostatinanalogen zur behandlung von melanomen
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
EP0235904A3 (de) Behandlung von Allergie mit Thymopentin
DE3875637D1 (de) Zusammensetzungen und verfahren zur behandlung von magengeschwueren.
HK139796A (en) Use of stomatostatin in the manufacture of a medicament for the treatment of rheumatoid arthritis
DE68908445T2 (de) Mittel zur Behandlung von Lebererkrankungen.
KR920700539A (ko) 해중 오염방지 처리 조성물
GR74351B (de)
ATE86857T1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition